Caitong International Asset Management’s Kezar Life Sciences KZR Stock Holding History

Caitong International Asset Management’s Portfolio KZR Stock Details KZR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-308	Closed	-$2.29K	–	3252
2026 Q1	$2.29K	Buy	+308	New	+$2K	﹤0.01%	1220

Caitong International Asset Management's KZR Position: Q2 2026 in Review

Caitong International Asset Management sold out of Kezar Life Sciences (KZR) in Q2 2026, closing a stake of 308 shares — an estimated $2.29K sold.

Caitong International Asset Management first reported a position in KZR in Q1 2026 and held it in 1 quarter. The position peaked at $2.29K in Q1 2026. 0 funds tracked by Wall St. Rank hold KZR as of Q2 2026.

Caitong International Asset Management reported no remaining Kezar Life Sciences position as of Q2 2026 after selling out during the quarter.
Caitong International Asset Management sold 308 Kezar Life Sciences shares in Q2 2026, an estimated $2.29K.
Caitong International Asset Management first reported a position in Kezar Life Sciences in Q1 2026 and held it in 1 quarter.
Caitong International Asset Management's Kezar Life Sciences position peaked at $2.29K in Q1 2026.
0 funds tracked by Wall St. Rank held Kezar Life Sciences as of Q2 2026.

Based on Caitong International Asset Management's 13F filing for Q2 2026, filed 5 Aug 2026.